-
Sakura Finetek Europe announces the launch of its newest advancement in tissue sample identification bringing laboratory workflows to the next level.
May 28, 2024
-
PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights. The product pairing provides unprecedented single-cell and spatial resolution of the tumor microenvironment from routine pathology samples to facilitate biomarker discovery and deeper understanding of treatment response for the next generation of cancer therapeutics. The expansion of the Explore™ portfolio comes at a time when AI-pathology is experiencing accelerated large-scale adoption across the diagnostic and biopharma industries.
“As cancer rates continue to rise, the demand for advanced precision medicine tools that provide accurate biological in
May 28, 2024
-
May 26, 2024
-
May 12, 2024
-
The Centralized Inventory System is predicted to see growth across both clinical trials and biobanking services as new report highlights risk factors with current approaches
May 23, 2024
-
May 22, 2024
-
Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors
May 22, 2024
-
May 21, 2024
-
May 21, 2024
-
PathAI, a global leader in AI-powered pathology, today announced a new Early Access Program (EAP) to drive adoption of its AISightTM Image Management System (IMS) in Mainland Europe.1 Earlier in 2023, PathAI announced a similar program for laboratories in the United States, which attracted over 50 laboratories with many exploring long-term use of PathAI’s AISight Image Management System and broad menu of AI Products.
May 20, 2024
-
Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).
May 19, 2024
-
Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.
May 19, 2024
-
May 15, 2024
-
Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.
May 14, 2024
-
Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards
May 14, 2024
-
Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.
May 14, 2024
-
Takara Bio announces the launch of PrimeCap™ T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development.
May 14, 2024
-
Elsevier, a global leader in information and analytics, today announced the launch of SciBite Chat, a new AI-powered interface built atop SciBite Search, SciBite’s award-winning platform. SciBite Chat uniquely combines the strength of semantic search for accurate and traceable information retrieval and Large Language Models (LLMs) for interpreting human language and answer generation.
May 14, 2024
-
PLUTO’s embeddings will enable prediction of underlying molecular alterations driving cancer and disease phenotypes–including those previously hidden to AI–as well as the discovery of new biomarkers and therapeutic targets.
May 13, 2024
-
Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.
May 13, 2024